MEXICO CITY (Reuters) – Mexico plans to start phase III clinical trials for China’s Walvax Biotechnology’s COVID-19 vaccine on May 30 and 6,000 volunteers are expected to participate, foreign minister Marcelo Ebrard said on Tuesday.
(Reporting by Anthony Esposito; Editing by Andrew Heavens)
